Letter from Yale-New Haven Hospital president after potential ca - WFSB 3 Connecticut

Letter from Yale-New Haven Hospital president after potential case of Ebola

Posted: Updated:

Dear Colleagues:

On Wednesday evening Yale-New Haven Hospital admitted a patient who met the threshold to be monitored for Ebola virus disease (EVD). The Hospital is working with the Centers for Disease Control and Prevention and the State Department of Public Health to have the patient tested for EVD. The Hospital's Incident Command System (HICS) is currently overseeing operations related to the monitoring and care of the patient. Abe Lopman, Senior Vice President, is incident commander and Victor Morris, MD, Associate Chief Medical Officer, is the medical director in the command structure. Guidance, resources, and communication for the hospital will cascade from the Command Center.

As we continue to evaluate and monitor the patient, it is important to review our preparations so far:

Morning Huddle

At 8:30 am every day, the Incident Management team is meeting to coordinate planning around screening potential EVD patients and treatment of patients who are confirmed to have EVD. It is expected that relevant information communicated during this meeting is passed along to employees through established communications channels and through our management structure.

Procedures and Protocols

A multidisciplinary team has worked to update all procedures and protocols related to the care of patients with infectious diseases. These include information on, but not limited to, screening, isolation, transport, inpatient care, laboratory testing, imaging, cleaning and waste removal. These protocols will be available via the clinical work stations and hospital intranet.

Treatment Locations

All employees are expected to understand their role in supporting and treating all patients, including those who have or may have EVD. Some areas in the hospital are more likely to encounter such patients. The emergency department is training staff at all four ED locations on screening patients and on protocols for when a patient has been determined to be symptomatic. Additionally, specific rooms on WP 8, WP 9 and NP 9 and 10 have been identified as areas for treatment of patients with suspect and confirmed EVD.


A new, hospital-wide training program has been developed. Additional resources are being dedicated to this effort to ensure it is comprehensive and readily available for staff.

Our EVD preparation will be continuously refined, especially as we learn from and collaborate with our state and federal government partners and other medical centers. We will continue to keep you informed, and if you have any questions or concerns, please direct them to your manager or supervisor.

Thank you in advance for your cooperation and commitment to our patients.

Rick Tom

Richard D'Aquila Thomas Balcezak, M.D.

President Chief Medical Officer

Yale-New Haven Hospital Yale-New Haven Hospital